NCT02815150 is a NA clinical trial of preoperative oral carbohydrate drink in Gastric Cancer, sponsored by First Affiliated Hospital, Sun Yat-Sen University.

Who is sponsoring NCT02815150?

NCT02815150 is sponsored by First Affiliated Hospital, Sun Yat-Sen University.

What drugs are being tested in NCT02815150?

Interventions in NCT02815150: preoperative oral carbohydrate drink.

What condition does NCT02815150 study?

NCT02815150 studies Gastric Cancer.

Is NCT02815150 still recruiting?

NCT02815150 is currently completed. Last updated 4 March 2025.

Last reviewed 2025-03-04 · How we verify

NCT02815150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients

Completed NA Last updated 4 March 2025

What this trial tests

NA trial testing preoperative oral carbohydrate drink in Gastric Cancer in 88 participants. Completed in 30 January 2019.

Timeline

1 April 2016

Primary endpoint
6 January 2019

30 January 2019

Quick facts

Lead sponsor	First Affiliated Hospital, Sun Yat-Sen University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	88
Start date	1 April 2016
Primary completion	6 January 2019
Estimated completion	30 January 2019
Sites	1 location across China

Drugs / interventions tested

preoperative oral carbohydrate drink

Conditions studied

Gastric Cancer — all drugs for Gastric Cancer →

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Who can join

Adults 18 to 80, any sex, with Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the impact of preoperative oral carbohydrate drink on gastric emptying and PH of gastric fluid in gastric cancer patients directly. Furthermore, investigators aim to evaluate the safety and effectiveness of preoperative oral carbohydrate in elective gastric cancer surgery, providing direct evidence for clinical practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Gastric residual volume, safety, and effectiveness of drinking 250 mL of glucose solution 2-3 hours before surgery in gastric cancer patients: a multicenter, single-blind, randomized-controlled trial.
Yang D, Hou X, Fu H, Song W, et al · · 2024 · cited 3× · PMID 39281267 · DOI 10.1093/gastro/goae077

Verify or expand the search:

Other recruiting trials for Gastric Cancer

Currently open trials in the same condition.

NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting

Other First Affiliated Hospital, Sun Yat-Sen University trials

Trials by the same sponsor.

NCT07322835 — Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China · not yet recruiting
NCT07322848 — DEB-TACE vs cTACE in HCC After TIPS · Phase 3 · recruiting
NCT07087418 — AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases · recruiting
NCT07014475 — Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI · not yet recruiting
NCT06951334 — Clinical Trial of Vildagliptin in Early Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02815150 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital, Sun Yat-Sen University
Last refreshed: 4 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02815150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing